A Randomized Control Trial Examining Two Treatments for Problem Gambling

February 11, 2013 updated by: Lorne Korman, Centre for Addiction and Mental Health
Despite evidence of high rates of concurrent substance use and anger problems among problem gamblers, until recently there have been no empirically evaluated treatments for these co-morbid problems. A recent study (Korman, Collins, McMain, & Skinner, 2005) found that an emotion and behaviour regulation treatment (EBRT) was more effective than a gambling-only treatment-as-usual in engaging clients in treatment and in reducing gambling, anger, and substance use. This study is a replication of Korman et al's study and will compare an emotion and behaviour regulation treatment (EBRT) for problem gambling, anger and substance use to a manualized cognitive behavioural treatment (CBT) for problem gambling.

Study Overview

Status

Withdrawn

Conditions

Intervention / Treatment

Detailed Description

80 participants will be randomly assigned to either an emotion and behaviour regulation treatment (EBRT) or to a cognitive behavioural treatment (CBT). Randomization will be stratified by the presence of substance dependence disorder. Both treatment conditions will consist of 12 one-hour weekly outpatient individual sessions. Participants will be assessed at baseline, end of treatment, and 3-months, 6-months and 12-months follow-up.

Study Type

Interventional

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Problem gambling (PGSI > 7; c.f., Ferris & Wynne, 2001)
  • Clinically significant anger (STAXI-II anger expression/trait subscale score >75th percentile and/or Anger Control subscale score < 25th percentile; c.f., Spielberger, 1999)

Exclusion Criteria:

  • Major thought disorders
  • Acute manic episode
  • High psychopathy
  • Severe developmental/cognitive disability
  • Outstanding legal charges/sentencing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Treatment Retention
The Working Alliance Inventory - Client version (WAI-C)
Canadian Problem Gambling Inventory(CPGI)
State-Trait Anger Expression Inventory-II(STAXI-II)
Addiction Severity Index: Drug and Alcohol Use section
Structured Clinical Interview for the DSM-IV (SCID; APA, 1994), substance use section

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Centre for Addiction and Mental Health

Investigators

  • Principal Investigator: Lorne Korman, PhD, BC Mental Health and Addiction Services

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Primary Completion (Actual)

November 1, 2006

Study Registration Dates

First Submitted

June 27, 2006

First Submitted That Met QC Criteria

June 27, 2006

First Posted (Estimate)

June 28, 2006

Study Record Updates

Last Update Posted (Estimate)

February 13, 2013

Last Update Submitted That Met QC Criteria

February 11, 2013

Last Verified

February 1, 2013

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 004/2006

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anger

Clinical Trials on Emotion and Behaviour Regulation Treatment (EBRT)

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe